FindTrial
Sign In

complications of injection given in the eye for retinal diseases

to study complications of intraviteral injection of bevacizumab

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2015/10/006250
Enrollment
100
Registered
2015-10-12
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- healthy patients who had given intravitreal bevacizumab for ocular problem

Interventions

Intervention1: nil: nil Control Intervention1: nil: nil

Sponsors

NETHRADHAMA SUPERSPECIALITY EYE HOSPITAL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: •Age > 18 years •Any evidence of ocular neovascularisation, Choroidal neovasular membrane, macular edema due to retinal vein occlusion, diabetic retinopathy

Exclusion criteria

Exclusion criteria: •Active external eye infection like conjunctivitis, meibomitis etc. •Ischemic maculopathy •Presence of any active systemic infections

Design outcomes

Primary

MeasureTime frame
To study ocular complications within a year of intravitreal injection of bevacizumab. Timepoint: day1 and at 1 month—

Secondary

MeasureTime frame
nilTimepoint: nil—

Countries

India

Contacts

Public Contactsonia gupta

Nethradhama superspeciality eye hospital

soniagupta17@yahoo.co.in9827077038

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026